Orum Therapeutics, Inc. (KOSDAQ: A475830)
Health Care · Biotechnology · KR
₩21,150.00
-15.40% today · -39.7% 1Y
Orum Therapeutics, Inc. (KOSDAQ: A475830) operates in the Biotechnology industry within the Health Care sector. The company is valued at $341.62M.
Over the last twelve months the share price has lost 39.7%, trading between 20.85K and 146.60K.
Tweenvest scores Orum Therapeutics, Inc. across four factors: quality 52/100, value 21/100. Its strongest factor is quality.
A475830 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $341.62M
- Revenue (TTM)
- $26.19K
- P/E
- —
- EPS
- -2,752.30
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩146,600.00
- 52-week low
- ₩20,850.00
- Avg volume (3M)
- —
- Shares outstanding
- 21.75M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jiangsu Recbio Technology Co., Ltd.SEHK: 2179 | $346.25M | HK$4.41 | +0.11% |
| Surrozen, Inc.NasdaqCM: SRZN | $344.61M | $25.15 | -14.24% |
| Jiangsu Gdk Biological Technology Co., LtdSHSE: 688670 | $344.01M | CN¥18.73 | +2.86% |
| Artiva Biotherapeutics, Inc.NasdaqGM: ARTV | $342.23M | $7.00 | -3.71% |
| Agenus Inc.NasdaqCM: AGEN | $340.80M | $7.57 | +1.07% |
| 3-D Matrix, Ltd.TSE: 7777 | $340.80M | ¥420.00 | +0.72% |
| Beijing Luzhu Biotechnology Co., Ltd.SEHK: 2480 | $339.67M | HK$13.40 | -2.90% |
| Ocugen, Inc.NasdaqCM: OCGN | $339.11M | $1.00 | -3.85% |
Figures last refreshed Oct 4, 2026.